HR001 was discovered to acquire an efficacious reaction for people with relapsed/refractory non-Hodgkin lymphoma.We analyzed the effects of elimusertib therapy on cell-cycle Handle and genomic instability. All in vitroThe many genes about the DDR panel are annotated with OncoKB, a precision oncology awareness foundation which happens to be publicly